121
Participants
Start Date
January 31, 2004
Primary Completion Date
December 31, 2013
Study Completion Date
June 15, 2016
filgrastim
Given SC
Anti-Thymocyte Globulin
Given IV
busulfan
Given IV
fludarabine phosphate
Given IV
methotrexate
Given IV
tacrolimus
Given PO or IV
Allogeneic Hematopoietic Stem Cell Transplantation
Undergo allogeneic PBSC transplantation
New York Weill Cornell Cancer Center at Cornell University, New York
Mount Sinai Medical Center, New York
CCOP - North Shore University Hospital, Manhasset
Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset
Long Island Jewish Medical Center, New Hyde Park
Monter Cancer Center of the North Shore-LIJ Health System, Lake Success
CCOP - Christiana Care Health Services, Newark
Tunnell Cancer Center at Beebe Medical Center, Lewes
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore
Union Hospital of Cecil County, Elkton
Masonic Cancer Center at University of Minnesota, Minneapolis
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Massachusetts General Hospital, Boston
Dana-Farber/Brigham and Women's Cancer Center, Boston
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township
Roswell Park Cancer Institute, Buffalo
Wake Forest University Comprehensive Cancer Center, Winston-Salem
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER